Skip to main content
SpringerLink
Log in

[18F]Fluoropyridines: From Conventional Radiotracers to the Labeling of Macromolecules Such as Proteins and Oligonucleotides

  • Conference paper
PET Chemistry

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 64))

Abstract

Molecular in vivo imaging with the high-resolution and sensitive positron emission tomography (PET) technique requires the preparation of a positron-emitting radiolabeled probe or radiotracer. For this purpose, fluorine-18 is becoming increasingly the radionuclide of choice due to its adequate physical and nuclear characteristics, and also because of the successful use in clinical oncology of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG), which is currently the most widely used PET-radiopharmaceutical and probably the driving force behind the growing availability and interest for this positron-emitter in radiopharmaceutical chemistry. With a few exceptions, radiofluorinations involving fluorine-18 of high specific radioactivity (e.g. > 185 GBq/µmole) had, until recently, been limited to nucleophilic substitutions in homoaromatic and aliphatic series with [18F]fluoride. Considering chemical structures showing a fluoropyridinyl moiety, nucleophilic heteroaromatic substitution at the ortho-position with no-carrier-added [18F]fluoride, as its K[18F]F-K222 complex, appears today as a highly efficient method for the radiosynthesis of radiotracers and radiopharmaceuticals. This chapter summarizes the recent applications of this methodology and highlights its potential in the design and preparation of, often drug-based, fluorine-18-labeled probes of high specific radioactivity for PET imaging, including macromolecules of biological interest such as peptides, proteins and oligonucleotides.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abreo MA, Lin N-H, Garvey DS, Gunn DE, Hettinger A-M, Wasicak JT, Pavlik PA, Martin YC, Donnelly-Roberts DL, Anderson DJ, Sullivan JP, Williams M, Arneric SP, Holladay MW (1996) Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J Med Chem 39:817–825

    PubMed  CAS  Google Scholar 

  • Aksenov VV, Vlasov VM, Moryakina IM, Rodionov PP, Fadeeva VP, Chertok VS, Yakobson GG (1985) Interaction of chloroaromatic compounds with alkali metal fluorides in the presence of crown-ethers. J Fluor Chem 28:73–88

    CAS  Google Scholar 

  • Amartey JK, Al-Jammaz I, Al-Otaibi B, Esguerra C (2002) Novel synthesis of 2-[18F]-fluoroisonicotinic acid hydrazide and initial biological evaluation. Nucl Med Biol 29:817–823

    PubMed  CAS  Google Scholar 

  • Bagot-Gueret C, Le Bas M-D, Tymciu S, Darabantu M, Emond P, Guilloteau D, Lasne M-C, Wijkhuisen A, Barré L, Perrio C (2003) Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors. Bioconj Chem 14:629–641

    CAS  Google Scholar 

  • Ballinger J, Bowen BM, Firnau G, Garnett ES, Teare FW (1984) Radiofluorination with reactor-produced cesium [18F]fluoride: no-carrier-added 2-[18F]fluoronicotine and 6-[18F]fluoronicotine. Int J Appl Radiat Isot 35:1125–1128

    CAS  Google Scholar 

  • Bartoli G, Latrofa A, Naso F, Todesco PE (1972) Fluorodenitration of some midly activated nitro-compounds. J Chem Soc — Perkin Trans I, 21:2671

    Google Scholar 

  • Beer H-F, Haeberli M, Ametamey S, Schubiger PA (1995) Comparison of two synthetic methods to obtain [18F]-N-(2-aminoethyl)-5-fluoropyridine-2-carboxamide, a potential MAO-B imaging tracer for PET. J Label Compds Radiopharm 36:933–945

    CAS  Google Scholar 

  • Boisgard R, Kühnast B, Vonhoff S, Younes C, Hinnen F, Verbavatz J-M, Rousseau B, Fuerste JP, Wlotzka B, Dollé F, Klussmann S, Tavitian B (2005) In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals. Eur J Nucl Med Mol Imaging 32:470–477

    PubMed  CAS  Google Scholar 

  • Bottlaender M, Valette H, Roumenov D, Dollé F, Coulon C, Ottaviani M, Hinnen F, Ricard M (2003) Biodistribution and radiation dosimetry of [18F]fluoro-A-85380 in healthy volunteers. J Nucl Med 44:596–601

    PubMed  CAS  Google Scholar 

  • Browne E, Dairiki JM, Doebler RE (1978) Table of isotopes. Lederer CM, Shirley VS (eds). Wiley-Interscience Pub, New York — Chichester — Brisbane — Toronto, pp 1–1523

    Google Scholar 

  • Carroll FI, Lee JR, Navarro HA, Brieaddy LE, Abraham P, Damaj MI, Martin BR (2001) Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′-substituted-3′-phenyl-5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist. J Med Chem 44:4039–4041

    PubMed  CAS  Google Scholar 

  • Carroll IF, Lee JR, Navarro HA, Ma W, Brieaddy LE, Abraham P, Damaj MI, Martin BR (2002) Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2′,3′-disubstituted 5′-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues. J Med Chem 45:4755–4761

    PubMed  CAS  Google Scholar 

  • Carroll FI, Ware R, Brieaddy LE, Navarro HA, Damaj MI, Martin BR (2004) Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2′-fluoro-3′-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist. J Med Chem 47:4588–4594

    PubMed  CAS  Google Scholar 

  • Chan L, Stefanac T, Turcotte N, Hu Z, Chen Y, Bedard J, May S, Jin H (2000) Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors. Bioorg Med Chem Lett 10:1477–1480

    PubMed  CAS  Google Scholar 

  • Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED (1999) 2-[18F]F-A-85380: A PET radioligand for α4β2 nicotinic acetylcholine receptors. NeuroReport 10:2715–2721

    PubMed  CAS  Google Scholar 

  • Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG (2003) Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 48:25–34

    PubMed  CAS  Google Scholar 

  • Clark JH, Macquarrie DJ (1987) The synthesis of organofluorine compounds using potassium fluoride-tetraphenylphosphonium bromide systems. Tetrahedron Lett 28:111–114

    CAS  Google Scholar 

  • Coenen HH, Klatte B, Knöchel A, Schüller M, Stöcklin G (1986) Preparation of n.c.a. [17/18F]-fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination. J Label Compds Radiopharm 23:455–467

    CAS  Google Scholar 

  • Cosford NDP, Govek SP, Hamill TG, Kamenecka T, Roppe JR, Seiders TJ (2004) Preparation of isotopically labeled heterocyclic alkyne derivatives as tracers for metabotropic glutamate receptor binding. PCT Int Appl, 73 pp, WO 2004038374

    Google Scholar 

  • de Bruin B, Kühnast B, Hinnen F, Yaouancq L, Amessou M, Johannes L, Samson A, Boisgard R, Tavitian B, Dollé F (2005) 1-[3-(2-[18F]Fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: Design, synthesis and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconj Chem 16:406–420

    Google Scholar 

  • Deuther-Conrad W, Patt JT, Feuerbach D, Wegner F, Brust P, Steinbach J (2004) Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. Farmaco 59:785–792

    PubMed  CAS  Google Scholar 

  • Differding E, Frick W, Lang RW, Martin P, Schmit C, Veenstra S, Greuter H (1990) Fluorinated heterocycles: targets in the search for bioactive compounds and tools for their preparation. Bull Soc Chim Belg 99:647–671

    CAS  Google Scholar 

  • Ding YS, Gatley J, Fowler JS, Volkow ND, Aggarwal D, Logan J, Dewey SL, Liang F, Carroll FI, Kuhar MJ (1996) Mapping nicotinic acetylcholine receptors with PET. Synapse 24:403–407

    PubMed  CAS  Google Scholar 

  • Ding YS, Liang F, Fowler JS, Kuhar MJ, Carroll FI (1997) Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: New PET ligands for mapping nicotinic acetylcholine receptors. J Label Compds Radiopharm 39:828–832

    Google Scholar 

  • Ding Y-S, Molina PE, Fowler JS, Logan J, Volkow ND, Kuhar MJ, Carroll FI (1999) Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. Nucl Med Biol 26:139–148

    PubMed  CAS  Google Scholar 

  • Ding Y-S, Logan J, Bermel R, Garza V, Rice O, Fowler JS, Volkow ND (2000a) Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine. J Neurochem 74: 1514–1521

    PubMed  CAS  Google Scholar 

  • Ding Y-S, Liu N, Wang T, Marecek J, Garza V, Ojima I, Fowler JS (2000b) Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. Nucl Med Biol 27:381–389

    PubMed  CAS  Google Scholar 

  • Ding Y-S, Fowler JS, Logan J, Wang G-J, Telang F, Garza V, Biegon A, Pareto D, Rooney W, Shea C, Alexoff D, Volkow ND, Vocci F (2004) 6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: Studies in the human brain and in vivo demonstration of specific binding in white matter. Synapse 53:184–189

    PubMed  CAS  Google Scholar 

  • Dolci L, Dollé F, Jubeau S, Vaufrey F, Crouzel C (1999a) 2-[18F]Fluoropyridines by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222 — A comparative study. J Label Compds Radiopharm 42:975–985

    CAS  Google Scholar 

  • Dolci L, Dollé F, Valette H, Vaufrey F, Fuseau C, Bottlaender M, Crouzel C (1999b) Synthesis of a fluorine-18 labelled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging. Bioorg Med Chem 7:467–479

    PubMed  CAS  Google Scholar 

  • Dollé F, Hinnen F, Vaufrey F, Tavitian B, Crouzel C (1997) A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imaging. J Label Compds Radiopharm 39:319–330

    Google Scholar 

  • Dollé F, Valette H, Bottlaender M, Hinnen F, Vaufrey F, Guenther I, Crouzel C (1998) Synthesis of 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J Label Compds Radiopharm 41:451–463

    Google Scholar 

  • Dollé F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C (1999) Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A new positron emission tomography ligand for nicotinic receptors. J Med Chem 42:2251–2259

    CAS  Google Scholar 

  • Dollé F (2004) Preparation of [18F]-labeled maleimides, their use for marking macromolecules for medical imaging. PCT Int Appl, 58 pp, WO 2004002984

    Google Scholar 

  • Dollé F (2005) Fluorine-18-labelled fluoropyridines: Advances in radiopharmaceutical design. Curr Pharm Design 11:3221–3235

    Google Scholar 

  • Finger GC, Starr LD, Dickerson HS, Gutowsky HS, Hamer J (1963) Aromatic fluorine compounds — XI: Replacement of chlorine by fluorine in halopyridines. J Org Chem 28:1666–1668

    CAS  Google Scholar 

  • Gallezot J-D, Bottlaender M, Grégoire M-C, Roumenov D.; Deverre J-R, Coulon C, Ottaviani M, Dollé F, Syrota A, Valette H (2005) In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. J Nucl Med 46:240–247

    PubMed  CAS  Google Scholar 

  • Gatley JS, Ding Y-S, Brady D, Gifford AN, Dewey SL, Carroll FI, Fowler JS, Volkow ND (1998) In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronorchloroepibatidine in rodent and human brain. Nucl Med Biol 25:449–454

    PubMed  CAS  Google Scholar 

  • Gundisch D, Koren AO, Horti AG, Pavlova OA, Kimes AS, Mukhin AG, London ED (2005) In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for α4b2* nicotinic acetylcholine receptors. Synapse 55:89–97

    PubMed  Google Scholar 

  • Gueret C, Bas MD, Perrio C, Dauphin F, Dhilly M, Chazalviel L, Emond P, Chalon S, Tymciu S, Guilloteau D, Lasne M-C, Barre L (2001) Synthesis and radiosynthesis with a positron emitter of EP 00652218, a potent antagonist of NK1 receptor, and a fluoro analog for in vivo evaluation of the substance P receptor by PET. J Label Compds Radiopharm 44:S283–S285

    Google Scholar 

  • Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238

    PubMed  CAS  Google Scholar 

  • Hamer J, Link WJ, Jurjevich A, Vigo TL (1962) Preparation of 2-fluoroquinoline and 2,6-difluoropyridine by halogen exchange. Rec Trav Chim Pays-Bas 81:1058–1060

    CAS  Google Scholar 

  • Hamzavi R, Dollé F, Tavitian B, Dahl O, Nielsen P (2003) Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconj Chem 14:941–954

    CAS  Google Scholar 

  • Hedberg E, Låangström B (1997) Synthesis of 4-([18F]fluoromethyl)phenyl isothiocyanate and its use in labeling oligonucleotides. Acta Chem Scand 51:1236–1240

    CAS  Google Scholar 

  • Hedberg E, Låangström B (1998) 18F-Labeling of oligonucleotides using succinimido 4-[18F]fluorobenzoate. Acta Chem Scand 52:1034–1039

    CAS  Google Scholar 

  • Hitzke J (1980) Fluorination of hexachlorobenzene and pentachloropyridine in a medium of solid potassium fluoride. J Fluor Chem 16:103–128

    CAS  Google Scholar 

  • Hocke C, Prante O, Loeber S, Huebner H, Gmeiner P, Kuwert T (2005) Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents. Bioorg Med Chem Lett 15:4819–4823

    PubMed  CAS  Google Scholar 

  • Holladay MW, Wasicak JT, Lin N-H, He Y, Ryther KB, Bannon AW, Buckley MJ, Kim DJB, Decker MW, Anderson DJ, Campbell JE, Kuntzweiller TA, Donnelly-Roberts DL, Piattoni-Kaplan M, Briggs CA, Williams M, Arneric SP (1998a) Identification and structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J Med Chem 41:407–412

    PubMed  CAS  Google Scholar 

  • Holladay MW, Bai H, Li Y, Lin NH, Daanen JF, Ryther KB, Wasicak JT, Kincaid JF, Hettinger AM, Huang P, Anderson DJ, Bannon AW, Buckley MJ, Campbell JE, Donnelly-Roberts DL, Gunther KL, Kim DJB, Kuntzweiler TA, Sullivan JP, Decker MW, Arneric SP (1998b) Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice. Bioorg Med Chem Lett. 8:2797–2802

    PubMed  CAS  Google Scholar 

  • Horti AG, Ravert HT, London ED, Dannals RF (1996) Synthesis of a radiotracer for studying nicotinic acetylcholine receptors: (±)-exo-2-(2-[18F]Fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane. J Label Compds Radiopharm 28:355–365

    Google Scholar 

  • Horti AG, Scheffel U, Stathis M, Finley P, Ravert HT, London ED, Dannals RF (1997) Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors. J Nucl Med 38:1260–1265

    PubMed  CAS  Google Scholar 

  • Horti A, Koren AO, Ravert HT, Musachio JL, Mathews WB, London ED, Dannals RF (1998a) Synthesis of a radiotracer for studying nicotinic acetylcholine receptors: 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]A-85380). J Label Compds Radiopharm 41:309–318

    CAS  Google Scholar 

  • Horti AG, Scheffel U, Koren AO, Ravert HT, Mathews WB, Musachio JL, Finley PA, London ED, Dannals RF (1998b) 2-[18F]fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol 25:599–603

    PubMed  CAS  Google Scholar 

  • Horti AG, Chefer SI, Mukhin AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, London ED (2000) 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci 67:463–469

    PubMed  CAS  Google Scholar 

  • Hoyte RM, Zhang J-X, Lerum R, Oluyemi A, Persaud P, O’Connor C, Labaree DC, Hochberg RB (1992) Synthesis of halogen-substituted pyridyl and pyrimidyl derivatives of [3,2-c]pyrazolo corticosteroids: strategies for the development of glucocorticoid receptor mediated imaging agents. J Med Chem 45:5397–5405

    Google Scholar 

  • Huang Y, Zhu Z, Xiao Y, Laruelle M (2005) Epibatidine analogues as selective ligands for the α xβ 2-containing subtypes of nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 15:4385–4388

    PubMed  CAS  Google Scholar 

  • Joule JA, Mills K (2000) Heterocyclic chemistry (4th ed). Blackwell Science, Oxford — London — Edinburgh — Malden — Paris — Berlin — Tokyo, pp 1–589

    Google Scholar 

  • Karramkam M, Hinnen F, Vaufrey F, Dollé F (2003a) 2-, 3-and 4-[18F]Fluoropyridines by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222 — A comparative study. J Label Compds Radiopharm 46:979–992

    CAS  Google Scholar 

  • Karramkam M, Hinnen F, Berrehouma M, Hlavacek C, Vaufrey F, Halldin C, McCarron JA, Pike VW, Dollé F (2003b) Synthesis of a [6-pyridinyl-18F]-labelled fluoro derivative of WAY-100635 as a candidate radioligand for brain 5-HT1A receptor imaging with PET. Bioorg Med Chem 11:2769–2782

    PubMed  CAS  Google Scholar 

  • Kato TA, Hakura A, Mizutani T, Saeki K-I (2000) Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives. Mutat Res 465:173–182

    PubMed  CAS  Google Scholar 

  • Kidwai M, Kohli S, Kumar P (1998) Rapid side-chain chlorination of heterocyclic compounds using focused microwave irradiation. J Chem Res Synop 9:586–587

    Google Scholar 

  • Kidwai M, Sapra P, Bhushan KR (1999) A novel enzymic synthesis of 2-substituted naphtho[2,1-b]pyran-3-ones using microwaves. Indian J Chem Sect B 38:114–115

    Google Scholar 

  • Kilbourn MR, Dence CS, Welch MJ, Mathias CJ (1987) Fluorine-18 labeling of proteins. J Nucl Med 28:462–470

    PubMed  CAS  Google Scholar 

  • Kilbourn MR (1990) Fluorine-18 labeling of radiopharmaceuticals (Nuclear Science Series). Kilbourn MR (ed). National Academy Press, Washington, pp 1–149

    Google Scholar 

  • Kilbourn MR, Welch MJ (1986) Fluorine-18 labeled receptor based radiopharmaceuticals. Appl Rad Isot 37:677–683

    CAS  Google Scholar 

  • Kimes AS, Horti AG, London ED, Chefer SI, Contoreggi C, Ernst M, Friello P, Koren AO, Kurian V, Matochik JA, Pavlova O, Vaupel DB, Mukhin AG (2003) 2-[18F]F-A85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. FASEB 17:1331–1333

    CAS  Google Scholar 

  • Knust EJ, Machulla M-J, Molls M (1982a) 18F-production in a water target with high yields for 18F-labelling of organic compounds: Synthesis of 6-[18F]nicotinic acid diethylamide. J Label Compds Radiopharm 19:1643–1644

    Google Scholar 

  • Knust EJ, Mueller-Platz C, Schueller M (1982b) Synthesis, quality control and tissue distribution of 2-[18F]-nicotinic acid diethylamide, a potential agent for regional cerebral function studies. J Radioanal Chem 74:283–291

    CAS  Google Scholar 

  • Knust EJ, Machulla HJ, Astfalk C (1983) Radiopharmaceuticals V: 18F-labeling with water target produced fluorine-18 — Synthesis and quality control of 6-18F-nicotinic acid diethylamide. Radiochem Radioanal Lett. 55:249–255

    CAS  Google Scholar 

  • Kong JW, Hamann LG, Ruppar DA, Edwards JP, Marschke KB, Jones TK (2000) Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro-and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quinolines. Bioorg Med Chem Lett 10:411–414

    PubMed  CAS  Google Scholar 

  • Koren AO, Horti AG, Mukhin AG, Gündisch D, Kimes AS, Dannals RF, London ED (1998) 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: Synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem 41:3690–3698

    PubMed  CAS  Google Scholar 

  • Koren AO, Horti AG, Mukhin AG, Gündisch D, Dannals RF, London ED (2000) Synthesis and initial in vitro characterization of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine, a high-affinity radioligand for central nicotinic acetylcholine receptors. J Label Compds Radiopharm 43:413–423

    CAS  Google Scholar 

  • Koren AO, Schefer SI, Mukhin AG, Pavlova OA, Horti AG, Vaupel DB, London ED, Kimes AS (2001) 5-Iodo-6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine, a novel PET radioligand for nicotinic acetylcholine receptors: Synthesis and initial evaluation. J Label Compds Radiopharm 44:S257–S259

    Google Scholar 

  • Kühnast B, Dollé F, Vaufrey F, Hinnen F, Crouzel C, Tavitian B (2000a) Fluorine-18 labeling of oligonucleotides bearing chemically-modified ribose-phosphate backbones. J Label Compds Radiopharm 43:837–848

    Google Scholar 

  • Kühnast B, Dollé F, Terrazzino S, Rousseau B, Loc’h C, Vaufrey F, Hinnen F, Doignon I, Pillon F, David C, Crouzel C, Tavitian B (2000b) A general method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconj Chem 11:627–636

    Google Scholar 

  • Kühnast B, Dollé F, Tavitian B (2001) Fluorine-18 labeling of peptide nucleic acids. J Label Compds Radiopharm 45:1–11

    Google Scholar 

  • Kühnast B, Hinnen F, Boisgard R, Tavitian B, Dollé F (2003a). Fluorine-18 labelling of oligonucleotides: Prosthetic labelling at the 5′-end using the N-(4-[18F]fluorobenzyl)-2-bromoacetamide reagent. J Label Compds Radiopharm 46:1093–1103

    Google Scholar 

  • Kühnast B, Klussmann S, Hinnen F, Boisgard R, Rousseau B, Fürste JP, Tavitian B, Dollé F (2003b) Fluorine-18-and iodine-125 labelling of Spiegelmers. J Label Compds Radiopharm 46:1205–1219

    Google Scholar 

  • Kühnast B, Lagnel — de Bruin B, Hinnen F, Tavitian B, Dollé F (2004) Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-Bromo-N-[3-(2-[18F]fluoro-pyridin-3-yloxy)-propyl]-acetamide. Bioconj Chem 15:617–627

    Google Scholar 

  • Kühnast B, Hinnen F, Hamzavi R, Boisgard R, Tavitian B, Nielsen PE, Dollé F (2005) Fluorine-18 labelling of PNAs functionalized at their pseudo-peptidic backbone for imaging studies with PET. J. Label. Compds Radiopharm 48:51–61

    Google Scholar 

  • Lange CW, VanBrocklin HF, Taylor SE (2002) Photoconjugation of 3-azido-5-nitrobenzyl [18F]fluoride to an oligonucleotide aptamer. J Label Compds Radiopharm 45:257–268

    CAS  Google Scholar 

  • Lasne M-C, Perrio C, Rouden J, Barré L, Roeda D, Dollé F, Crouzel C (2002) Chemistry of β+-emitting compounds based on fluorine-18. In Krause W (ed) Topics in current chemistry. Springer-Verlag, Berlin — Heidelberg, vol 222, pp 201–258

    Google Scholar 

  • Liang F, Navarro HA, Abraham P, Kotian P, Ding YS, Fowler JS, Volkow ND, Kuhar MJ, Carroll FI (1997) Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2′-fluoro-5′-pyridinyl)-7-azabicyclo-[2.2.1]heptane: A new positron emission tomography ligand for nicotinic receptors. J Med Chem 40:2293–2295

    PubMed  CAS  Google Scholar 

  • Liu N, Ding Y-S, Wang T, Garza V, Fowler JS (2002) Synthesis of 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine as a radioligand for imaging nicotinic acetylcholine receptors. Nucl Sci Tech 13:92–97

    CAS  Google Scholar 

  • March JM (1992) Advanced organic chemistry — Reactions, mechanisms, and structures. March JM (ed). Wiley-Interscience Pub, New York — Chichester — Brisbane — Toronto, pp 1–1495

    Google Scholar 

  • Marzabal S, Terrazzino S, Kühnast B, Dollé F, Deverre J-R, Jobert A, Crouzel C, DiGiamberardino L, Tavitian B (1999) In vivo imaging and pharmacokinetics of oligonucleotides. Nucleosides Nucleotides 18:1731–1733

    CAS  Google Scholar 

  • Matthews RS (1998) 19F-NMR spectroscopy of polyhalonaphthalenes — Part IV: Halex reactions of polychloroquinolines. J Fluor Chem 91:203–206

    CAS  Google Scholar 

  • Matthews RS, Matthews AN (2000) 19F-NMR spectroscopy of polyhalonaphthalenes — Part V: Halex reactions of polychloroisoquinolines. J Fluor Chem 105:35–40

    CAS  Google Scholar 

  • McCarron JA, Pike VW, Halldin C, Sandell J, Sovago J, Gulyas B, Cselényi Z, Wikström HV, Marchais-Oberwinkler S, Nowicki B, Dollé F, Farde L (2004) The Pyridinyl-6 position of WAY-100635 as a site for radiofluorination — Effect on 5-HT1A receptor radioligand behavior in vivo. Mol Imag Biol 6:17–26

    Google Scholar 

  • Mitkovski S, Villemagne VL, Novakovic KE, O’Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Grégoire M-C, Bottlaender M, Dollé F, Rowe CC (2005) Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET. Nucl Med Biol 32:585–591

    PubMed  CAS  Google Scholar 

  • Miyamoto T, Egawa H, Shibamori K-I, Matsumoto J-I (1987) Pyridonecarboxylic acids as antibacterial agents — Part 10: Synthesis and reactions of 7-substituted 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids as antibacterial agents. J Heterocycl Chem 24:1333–1339

    CAS  Google Scholar 

  • Molina EP, Ding YS, Carroll FI, Liang F, Volkow ND, Pappas N, Kuhar M, Abumrad N, Gatley JS, Fowler JS (1997) Fluoro-norchloroepibatidine: Preclinical assessment of acute toxicity. Nucl Med Biol 24:743–747

    PubMed  CAS  Google Scholar 

  • Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497–1500

    PubMed  CAS  Google Scholar 

  • Nielsen PE, Egholm M (1999) Peptide Nucleic Acids: Protocols and applications. Horizon Scientific Press, Norfolk, 1–266

    Google Scholar 

  • Nolte A, Klussmann S, Bald R, Erdmann V, Fürste JP (1996) Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 14:1116–1119

    PubMed  CAS  Google Scholar 

  • Okarvi SM (2001) Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur J Nucl Med 28:929–938

    PubMed  CAS  Google Scholar 

  • Outt PE, Ares JJ, Roberts GE, Wang X, Cupps TL, Wireko FC (1998) A general synthesis of 4-substituted 6-[(2-imidazolidinylidene)amino]-5,8-dimethylquinolines. J Org Chem 63:5762–5768

    PubMed  CAS  Google Scholar 

  • Patt JT, Deuther-Conrad W, Wohlfarth K, Feuerbach D, Brust P, Steinbach J (2003) Norchloro-fluoro-homoepibatidine: 18F-labelling and evaluation of affinity and selectivity at neuronal nicotinic acetylcholine receptors. J Label Compds Radiopharm 46:S169

    Google Scholar 

  • Patt JT, Deuther-Conrad W, Brust P., Patt M., Sabri O, Steinbach J (2005) Norchloro-[18F]fluorohomoepibatidine: PET evaluation of tracer properties in pigs. J Label Compds Radiopharm 48:S90

    Google Scholar 

  • Peet NP, Sunder S (1986) Reinvestigation of a cyclization reaction of 2-hydrazino-3-(1H-pyrrol-1-yl)pyridine. Heterocycles 24:3213–3221

    CAS  Google Scholar 

  • Qaim SM, Stöcklin G (1983) Production of somemedically important short-lived neutron-deficient radioisotopes of halogens. Radiochim Acta 34:25–40

    CAS  Google Scholar 

  • Radl S, Hradil P (1991) Synthesis of some 1-alkyl-1,4-dihydro-4-oxo-1,7-naphthyridine-3-carboxylic acids. Collect Czech Chem Commun 56:2420–2429

    CAS  Google Scholar 

  • Rewcastle GW, Palmer BD, Thompson AM, Bridges AJ, Cody DR, Zhou H, Fry DW, McMichael A, Kraker AJ, Denny WA (1996) Tyrosine kinase inhibitors — 9: Synthesis and evaluation of fused tricyclic quinazoline analogs as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J Med Chem 39:1823–1835

    PubMed  CAS  Google Scholar 

  • Roger G, Lagnel B, Rouden J, Besret L, Valette H, Demphel S, Gopisetti J, Coulon C, Ottaviani M, Wrenn LA, Letchworth SR, Bohme GA, Benavides J, Lasne M-C, Bottlaender M, Dollé F (2003) Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (−)-cytisine as a candidate radioligand for brain nicotinic α4β2 receptor imaging with PET. Bioorg Med Chem 11:5333–5343

    PubMed  CAS  Google Scholar 

  • Roger G, Valette H, Hinnen F, Saba W, Coulon C, Ottaviani M, Bottlaender M, Dollé F (2005) Synthesis and radiosynthesis of [18F]FPhEP and [18F]F2PhEP, two novel high-affinity and α4β2-selective, epibatidine-based radioligands for PET imaging of nicotinic acetylcholine receptors. J Label Compds Radiopharm 48:S165

    Google Scholar 

  • Sakamoto N, Kurita Y, Yanagi K, Matsuo N (2000) Synthesis and reactivity of pyridylpyridone derivatives. J Org Chem 65:1225–1226

    PubMed  CAS  Google Scholar 

  • Sandell J, Halldin C, Pike VW, Chou YH, Varnas K, Hall H, Marchais S, Nowicki B, Wikström HV, Swahn CG, Farde L (2001) New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY — Radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey. Nucl Med Biol 28:177–185

    PubMed  CAS  Google Scholar 

  • Scheffel U, Horti AG, Koren AO, Ravert HT, Banta JP, Finley PA, London ED, Dannals RF (2000) 6-[18F]Fluoro-A-85380: an in vivo tracer for the nicotinic acetylcholine receptor. Nucl Med Biol 27:51–56

    PubMed  CAS  Google Scholar 

  • Schirrmacher R, Muehlhausen U, Waengler B, Schirrmacher E, Reinhard J, Nagel G, Kaina B, Piel M, Wiessler M, Roesch F (2002a) Synthesis of 2-amino-6-(2-[18F]fluoro-pyridine-4-ylmethoxy)-9-(octyl-β-D-glucosyl)-purine: a novel radioligand for positron emission tomography studies of the O6-methylguanine-DNA methyltransferase (MGMT) status of tumor tissue. Tetrahedron Lett 43:6301–6304

    CAS  Google Scholar 

  • Schirrmacher R, Nesseler E, Hamkens W, Eichhorn U, Schreckenberger M, Kaina B, Rosch F (2002b) An approach to the evaluation of the activity of the DNA repair enzyme O6-methylguanine-DNA-methyl-transferase in tumor tissue in vivo: syntheses of 6-benzyloxy-9-(2-[18F]fluoroethyl)-9H-purin-2-yl-amine and 6-benzyloxy-7-(2-[18F]fluoroethyl)-7H-purin-2-yl-amine. Appl Rad Isot 56:511–517

    CAS  Google Scholar 

  • Schmaljohann J, Minnerop M, Karwath P, Gündisch D, Falkai P, Guhlke S, Wullner U (2004) Imaging of central nAChReceptors with 2-[18F]F-A85380: Optimized synthesis and in vitro evaluation in Alzheimer’s disease. Appl Rad Isot 61:1235–1240

    CAS  Google Scholar 

  • Schmaljohann J, Gündisch D, Minnerop M, Joe A, Bucerius J, Dittmar C, Jessen F, Guhlke S, Wullner U (2005) A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. Appl Rad Isot 63:433–435

    CAS  Google Scholar 

  • Sledeski AW, Kubiak GG, O’Brien MK, Powers MR, Powner TH, Truesdale LK (2000) Efficient synthesis of AMP579, a novel adenosine A1/A2 receptor agonist. J Org Chem 65:8114–6118

    PubMed  CAS  Google Scholar 

  • Stöcklin GL(1998) Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)? Eur J Nucl Med 25:1612–1616

    Google Scholar 

  • Stöcklin G, Pike VW (1993) Radiopharmaceuticals for positron emission tomography. Cox PH (ed). Kluwer Academic Pub, Dordrecht — Boston — London, pp 1–178

    Google Scholar 

  • Sullivan JP, Donnelly-Roberts DL, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinary E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP (1996) A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand. Neuropharmacology 35:725–734

    PubMed  CAS  Google Scholar 

  • Tavitian B, Terrazzino S, Kühnast B, Marzabal S, Stettler O, Dollé F, Deverre JR, Jobert A, Hinnen F, Bendriem B, Crouzel C, DiGiamberardino L (1998) In vivo imaging of oligonucleotides with positron emission tomography. Nature Medicine 4:467–471

    PubMed  CAS  Google Scholar 

  • Tavitian B, Marzabal S, Boutet V, Kühnast B, Terrazzino S, Moynier M, Dollé F, Deverre J-R, Thierry AR (2002b) Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging. Pharm Res 19:367–376

    PubMed  CAS  Google Scholar 

  • Tavitian B (2003) In vivo imaging with oligonucleotides for diagnosis and drug development. Gut 52:iv40–iv47

    PubMed  CAS  Google Scholar 

  • Tavitian B (2004) Oligonucleotides as radiopharmaceuticals. Molecular Imaging — Ernst Schering Research Foundation Workshop, Springer Verlag, Berlin — Heidelberg — New York, vol 49, pp 1–34

    Google Scholar 

  • Valette H, Bottlaender M, Dollé F, Guenther I, Coulon C, Hinnen F, Fuseau C, Ottaviani M, Crouzel C (1999a) Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo. Life Sci 64:PL93–PL97

    PubMed  CAS  Google Scholar 

  • Valette H, Bottlaender M, Dollé F, Guenther I, Fuseau C, Coulon C, Ottaviani M, Crouzel C (1999b) Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380. J Nucl Med 40:1374–1380

    PubMed  CAS  Google Scholar 

  • Valette H, Dollé F, Bottlaender M, Marzin D (2002) Fluoro-A-85380 demonstrated no mutagenic properties in in vivo rat micronucleus and ames tests. Nucl Med Biol 29:849–853

    PubMed  CAS  Google Scholar 

  • Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A (2003) Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: A PET study in monkeys. J Neurochem 84:105–111

    PubMed  CAS  Google Scholar 

  • Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A (2005a) Acute effects of physostigmine and galantamine on the binding of [18F]fluoro-A-85380: A PET study in monkeys. Synapse 56:217–221

    PubMed  CAS  Google Scholar 

  • Valette H, Roger G, Saba W, Hinnen F, Coulon C, Ottaviani M, Syrota A, Dollé F, Bottlaender M (2005b) Radiosynthesis and preliminary PET evaluation of [18F]FPhEP, a novel epibatidine-based nicotinic α4β2 antagonist. J Nucl Med 46:346P

    Google Scholar 

  • Valk PE, Bailey DL, Townsend DW, Maisey MN (2003) Positron emission tomography — basic science and clinical practice. Valk PE, Bailey DL, Townsend DW, Maisey MN (eds). Springer, London — Berlin — Heidelberg — New York — Hong Kong — Milan — Paris — Tokyo, pp 1–884

    Google Scholar 

  • Varagnolo L, Stokkel MPM, Mazzi U, Pauvels EKJ (2000) 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. Nucl Med Biol 27:103–112

    PubMed  CAS  Google Scholar 

  • Vaupel DB, Tella SR, Huso DL, Wagner VO, Mukhin AG, Chefer SI, Horti AG, London ED, Koren AO, Kimes AS (2005) Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography. J Pharmacol Exp Ther 312:355–365

    PubMed  CAS  Google Scholar 

  • Villemagne VL, Horti AG, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN, Dannals RF (1997) Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J NuclMed 38:1737–1741

    CAS  Google Scholar 

  • Welch MJ, Redvanly CS (2003) Handbook of Radiopharmaceuticals — Radiochemistry and Applications. Welch MJ, Redvanly CS (ed). Wiley-Interscience Pub, New York — Chichester — Brisbane — Toronto, pp 1–848

    Google Scholar 

  • Wilbur DS (1992) Radiohalogenation of proteins: An overview of radionuclides, labeling methods and reagents for conjugate labeling. Bioconj Chem 3:433–470

    CAS  Google Scholar 

  • Wlotzka B, Leva S, Eschgfäller B, Burmeister J, Kleinjung F, Kaduk C, Muhn P, Hess-Stumpp H, Klussmann S (2002) In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class. Proc Natl Acad Sci USA 99:8898–8902

    PubMed  CAS  Google Scholar 

  • Younes CK, Boisgard R, Tavitian B (2002) Labelled oligonucleotides as radiopharmaceuticals: Pitfalls, problems and perspectives. Curr Pharm Design 8:1451–1466.

    CAS  Google Scholar 

  • Yu M, Tueckmantel W, Wang X, Zhu A, Kozikowski A, Brownell AL (2005) Synthesis and initial evaluation of 2-[18F]fluoro-5-[2-(2-methylthiazol-4-yl)ethynyl]pyridine, a potential PET ligand for the metabotropic glutamate subtype 5 receptor. J Label Compds Radiopharm 48:S138

    Google Scholar 

  • Zhang Y, Horti AG (2004) Synthesis of 6-chloro-3-[(2-(S)-azetidinyl)methoxy]-5-(2-[18F]fluoropyridin-4-yl)pyridine ([18F]NIDA 522131), a novel potential radioligand for studying extrathalamic nicotinic acetylcholine receptors by PET. J Label Compds Radiopharm 47:947–952

    CAS  Google Scholar 

  • Zhang Y, Hall AW, Horti AG (2004a) Efficient synthesis of 6-chloro-3-((2-(S)-azetidinyl)methoxy)-5-((E)-2-(2-[18F]fluoropyridin-4-yl)vinyl)pyridine ([18F]NIDA 52289), a very high affinity radioligand for nicotinic acetylcholine receptors. J Label Compds Radiopharm, 47:385–392

    CAS  Google Scholar 

  • Zhang Y, Pavlova OA, Chefer SI, Hall AW, Kurian V, Brown LL, Kimes AS, Mukhin AG, Horti AG (2004b) 5-Substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha-4-beta-2-nicotinic acetylcholine receptor and wide range of lipophilicity: Potential probes for imaging with positron emission tomography. J Med Chem 47:2453–2465

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Recherche Médicale — CEA, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91406, Orsay, France

    F. Dollé

Authors
  1. F. Dollé
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Animal Imaging Center — PET, Center for Radiopharmaceutical Science of ETH, PSI and USZ, ETH Hönggerberg D-CHAB, Wolfgang-Pauli Str. 10, 8093, Zürich, Switzerland

    P. A. Schubiger

  2. Corporate Research, Schering AG, Müller Str. 178, 13342, Berlin, Germany

    L. Lehmann  & M. Friebe  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Dollé, F. (2007). [18F]Fluoropyridines: From Conventional Radiotracers to the Labeling of Macromolecules Such as Proteins and Oligonucleotides. In: Schubiger, P.A., Lehmann, L., Friebe, M. (eds) PET Chemistry. Ernst Schering Research Foundation Workshop, vol 64. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-49527-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-49527-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-32623-6

  • Online ISBN: 978-3-540-49527-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation